Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

92 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-04-30

Study Completion Date

2021-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the benefits of giving filled prescription of a medication to be used upon early onset of symptoms of URTI induced asthma. The hope is to reduce the need to present to Health Care centres for treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Determinants Of Oral Corticosteroid Responsiveness in Wheezing Asthmatic Youth

NCT02013076

Asthma

COMPLETED

Inhaled Steroid Treatment as Regular Therapy in Early Asthma

NCT00641914

Asthma

COMPLETED PHASE4

Investigation of Lung Ventilation Inhomogeneity in Pediatric Asthma

NCT01095354

Asthma

COMPLETED

Antibiotics in Infancy--Risk Factor for Childhood Asthma

NCT00037726

Asthma Lung Diseases

COMPLETED

Remote Use of the Asthma Control Test (ACT) to Improve Care of Children With Asthma

NCT03036982

Asthma

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In Canada, asthma affects more the 12% of children. Exacerbation are a common feature of asthma. In children, upper respiratory tract infection (URTI's) are responsible for over 80% of asthma exacerbation.

Experts in asthma care acknowledge this critical problem and have developed guidelines to reduce asthma exacerbation.

The criteria for participation in this study to have 2 or more presentations to a Health Service centre in the past 12 months for URTI induced asthma. These patients will be followed and interviewed monthly over a 12 month period to investigate whether the use of Oral cortico-steroids upon early onset of URTI induced asthma prevents the need for presentation to hospital

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Upper Respiratory Tract Infection Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1 Oral Cortico Steroid

A filled prescription will be given to be used upon early onset of symptoms.

Group Type ACTIVE_COMPARATOR

Arm 1 Oral Cortico Steroids

Intervention Type DRUG

Prednisolone: 1 mg / kg per day course of dose for 5 days up to child's weight of 20 kgs.

Dexamethasone: 0.3mg/kg per dose for 3 days (minimum weight 20 kgs )

Usual care for Asthma treatment

monitor the readmission of URTI induced asthma in children over a 12 month period

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Arm 1 Oral Cortico Steroids

Prednisolone: 1 mg / kg per day course of dose for 5 days up to child's weight of 20 kgs.

Dexamethasone: 0.3mg/kg per dose for 3 days (minimum weight 20 kgs )

Intervention Type DRUG